SPRO 8-K 2026-08-28

Spero Therapeutics, Inc. (SPRO) 8-K dated 2026-08-28 — accession 0001193125-26-374788. This URL is the filing, not the SPRO hub.

Spero Therapeutics, Inc. (SPRO) is a biotechnology company listed on NASDAQ.

Spero Therapeutics, Inc. filed a 8-K on 2026-08-28. Accession 0001193125-26-374788.

Cached items: 1.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SPRO revenue for 2025-12-31 was $66.8M. Net income was $8.6M. Revenue was up 39.2% from 2024-12-31 to 2025-12-31. SPRO currently screens at market cap $149.5M.

Not investment advice. The SPRO SEC hub lists recent forms. The stock page is the research view.